
Feb 6 (Reuters) - Biogen Inc BIIB.O:
BIOGEN OUTLOOK 2026 ADJUSTED EPS $15.25 - $16.25 VERSUS IBES ESTIMATE $14.92
BIOGEN:SEES 2026 REVENUE TO DECLINE BY MID-SINGLE DIGIT PERCENTAGE VERSUS 2025
BIOGEN Q4 ADJUSTED EPS $1.99 VERSUS IBES ESTIMATE $1.59
BIOGEN Q4 REVENUE $2.28 BILLION VERSUS IBES ESTIMATE $2.20 BILLION
BIOGEN: Q4 LEQEMBI GLOBAL IN-MARKET SALES OF ABOUT $134 MILLION
FY2026 REVENUE VIEW $9.32 BILLION -- LSEG IBES DATA
Further company coverage: BIIB.O